2008
DOI: 10.1159/000149797
|View full text |Cite
|
Sign up to set email alerts
|

Hypothermic Injury: the Mitochondrial Calcium, ATP and ROS Love-Hate Triangle out of Balance

Abstract: Background/Aims: Catecholamines prevent hypothermic cell death which accounts for severe tissue damage and impaired allograft function after prolonged organ preservation. Here, we identified cellular processes which govern hypothermia-mediated cell death in endothelial cells and how they are influenced by dopamine. Methods: Lactate dehydrogenase assay, intracellular ATP, reactive oxygen species and reduced thio-group measurement, intracellular calcium measurement and mitochondrial calcium staining were perform… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
62
1

Year Published

2009
2009
2024
2024

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 81 publications
(70 citation statements)
references
References 41 publications
4
62
1
Order By: Relevance
“…Another study on ischemia/ reperfusion injury in neonate rat cardiomyocytes supports that cardiac D 1 receptors are not involved in cytoprotection, because selective activation of D 1 receptors with the agonist SKF-38393 (1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol) induces apoptotic cell death (Li et al, 2008). As NOD has been shown not to act on dopamine receptors (Lösel et al, 2010), our data clearly support that DA's cytoprotective action does not require dopamine receptor engagement (Brinkkoetter et al, 2006(Brinkkoetter et al, , 2008Benck et al, 2011). Direct evidence to underpin this assumption is provided by the data demonstrating that the protective effects of DA and NOD are not abrogated by the D 1 /D 2 receptor antagonist fluphenazine.…”
Section: Dopamine and Its Lipophilic Derivates Providesupporting
confidence: 74%
“…Another study on ischemia/ reperfusion injury in neonate rat cardiomyocytes supports that cardiac D 1 receptors are not involved in cytoprotection, because selective activation of D 1 receptors with the agonist SKF-38393 (1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol) induces apoptotic cell death (Li et al, 2008). As NOD has been shown not to act on dopamine receptors (Lösel et al, 2010), our data clearly support that DA's cytoprotective action does not require dopamine receptor engagement (Brinkkoetter et al, 2006(Brinkkoetter et al, , 2008Benck et al, 2011). Direct evidence to underpin this assumption is provided by the data demonstrating that the protective effects of DA and NOD are not abrogated by the D 1 /D 2 receptor antagonist fluphenazine.…”
Section: Dopamine and Its Lipophilic Derivates Providesupporting
confidence: 74%
“…Strategies that reduce intracellular calcium with novel hyperpolarizing preservation solutions have been shown to ameliorate ischemic damage during cold preservation in experimental heart transplantation (27). We were able to demonstrate that dopamine decelerates the deleterious amplification loop of intracellular calcium accumulation, and subsequent ATP consumption by scavenging of reactive oxygen species (9,30). These findings have been recently expanded and confirmed by in vitro studies with cardiomyocytes in culture (31).…”
Section: Clinical Outcomesmentioning
confidence: 52%
“…We recently presented a randomized, controlled clinical trial that showed that pre-treatment of brain-dead donors with low-dose dopamine of 4 g/kg/min reduces the dialysis requirement after kidney transplantation (8). The underlying mechanism is related to antioxidant properties of the dopamine molecule (9). In the particular setting of organ preservation, dopamine increases the tolerance of the kidney graft to withstand ischemic damage during cold storage.…”
Section: Discussionmentioning
confidence: 99%
“…Even in this reduced metabolic state, prolonged ischemic time leads to depletion of energy stores and subsequent loss of cellular integrity [15][16][17]. Providing additional oxygen as substrate for metabolism during both warm and cold ischemia, third generation PFCs are able to extend the period of time where aerobic metabolism is maintained and, therefore, delay the onset of tissue damage associated with prolonged preservation [18,19].…”
Section: Discussionmentioning
confidence: 99%